Year All202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998 BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium Sep 06, 2024 Read More BioCryst Appoints Dr. Donald Fong Chief Medical Officer Sep 05, 2024 Read More BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sep 04, 2024 Read More BioCryst to Present at Upcoming Investor Conferences Aug 22, 2024 Read More BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update Aug 05, 2024 Read More BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Aug 02, 2024 Read More BioCryst to Report Second Quarter 2024 Financial Results on August 5 Jul 22, 2024 Read More ORLADEYO® (berotralstat) Approved in Peru Jul 09, 2024 Read More BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jul 02, 2024 Read More BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 04, 2024 Read More
BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium Sep 06, 2024 Read More
BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update Aug 05, 2024 Read More